NASDAQ · INCR
Intercure financials
$5.23+2.75%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $270.2M | $238.8M | $355.6M | $388.7M | $219.7M |
| Gross profit | $33.2M | $30.2M | $105.1M | $155.1M | $91.1M |
| Gross margin | 12.3% | 12.7% | 29.6% | 39.9% | 41.5% |
| Operating income | -$27.2M | -$67.2M | -$41.6M | $50.6M | $28.2M |
| Net income | -$35.7M | -$67.8M | -$62.0M | $44.8M | $4.7M |
| Net margin | −13.2% | −28.4% | −17.4% | 11.5% | 2.1% |
| Diluted EPS | $-3.30 | $-7.40 | $-6.80 | $4.95 | $0.55 |
| EBITDA | -$8.1M | -$52.2M | -$27.7M | $62.5M | $37.4M |
| Operating cash flow | $16.8M | -$66.9M | -$53.6M | $51.3M | $30.1M |
| Free cash flow | $13.3M | -$71.3M | -$56.3M | $31.5M | $16.1M |
| Diluted shares | 10.7M | 9.2M | 9.1M | 9.1M | 7.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $46.5M | $78.3M | $101.1M | $232.6M | $196.2M |
| Short-term investments | $209.0K | $333.0K | $187.0K | $205.0K | $0.00 |
| Total debt | $191.7M | $225.2M | $225.5M | $227.7M | $82.4M |
| Total assets | $690.6M | $762.6M | $786.6M | $958.0M | $696.5M |
| Total liabilities | $294.2M | $364.9M | $329.6M | $436.5M | $227.1M |
| Shareholders' equity | $396.4M | $397.7M | $457.1M | $521.5M | $469.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology